TAXUS STENT DEMONSTRATES EXCELLENT EFFICACY AND SAFETY IN INDEPENDENT 'STENT' REGISTRY

Angiotech Pharmaceuticals' corporate partner, Boston Scientific, welcomed interim results from the independent, multicenter stent registry that further demonstrate the efficacy and safety of Boston Scientific's Taxus Express(2) paclitaxel-eluting coronary stent system among real-world patients with blocked coronary arteries.
PRNewswire